Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
Treasury Stock
Prestige Consumer Healthcare Inc
Treasury Stock Peer Comparison
Competitive Treasury Stock Analysis
Latest Figures & CAGR of Competitors
Company | Treasury Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Treasury Stock
-$219.6m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-71%
|
|
Johnson & Johnson
NYSE:JNJ
|
Treasury Stock
-$75.7B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-17%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Treasury Stock
-$43.7B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-10%
|
|
Pfizer Inc
NYSE:PFE
|
Treasury Stock
-$114.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-5%
|
|
Merck & Co Inc
NYSE:MRK
|
Treasury Stock
-$57.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-7%
|
|
Eli Lilly and Co
NYSE:LLY
|
Treasury Stock
-$3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
See Also
What is Prestige Consumer Healthcare Inc's Treasury Stock?
Treasury Stock
-219.6m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Treasury Stock amounts to -219.6m USD.
What is Prestige Consumer Healthcare Inc's Treasury Stock growth rate?
Treasury Stock CAGR 10Y
-71%
Over the last year, the Treasury Stock growth was -16%. The average annual Treasury Stock growth rates for Prestige Consumer Healthcare Inc have been -20% over the past three years , -30% over the past five years , and -71% over the past ten years .